Andera Partners - 30 Jun 2025 SCHEDULE 13G/A Report for MINERALYS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (MLYS)

Filing Manager
Andera Partners
Reporting Manager
Andera Partners
Security
MINERALYS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol
MLYS
Shares outstanding
65,856,571 shares
Disclosed Ownership
2,765,976 shares
Ownership
4.2%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:13:57 UTC
Date of event
30 Jun 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Andera Partners disclosed 4.2% ownership in MINERALYS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (MLYS) on 30 Jun 2025."

Quick Takeaways

  • Andera Partners filed SCHEDULE 13G/A for MINERALYS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (MLYS).
  • Disclosed ownership: 4.2%.
  • Date of event: 30 Jun 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 16:13.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Andera Partners 4.2% 2,765,976 0 2,765,976 /s/ Stephane Bergez By Stephane Bergez, Managing Partner
BioDiscovery 6 FPCI 4.2% 2,765,976 0 2,765,976 /s/ Stephane Bergez By Andera Partners, its management company, By Stephane Bergez, Managing Partner
Stephane Bergez 4.2% 2,765,976 0 2,765,976 /s/ Stephane Bergez Stephane Bergez
Francois Xavier Mauron 4.2% 2,765,976 0 2,765,976 /s/ Francois Xavier Mauron Francois Xavier Mauron

Sponsored